SCHEMBL12787019

SCHEMBL12787019

CC1(C)c2ccccc2N(Cc2ccc(CN3c4ccccc4C(C)(C)C34C=Cc3ccccc3O4)cc2)C12C=Cc1ccccc1O2

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 8/20 0.53
LMNA P02545 6/20 0.53
THRB P10828 5/20 0.53
GAA P10253 4/20 0.53
MEN1 O00255 4/20 0.53
KMT2A Q03164 4/20 0.53
SMN1; SMN2 Q16637 4/20 0.53
RECQL P46063 3/20 0.53
TDP1 Q9NUW8 3/20 0.53
PKM P14618 2/20 0.53
TSHR P16473 2/20 0.53
PLIN1 O60240 1/20 0.53
PLIN5 Q00G26 1/20 0.53
ABHD5 Q8WTS1 1/20 0.53
NPSR1 Q6W5P4 5/20 0.50
TP53 P04637 2/20 0.50
ALPG P10696 1/20 0.50
ALOX15 P16050 1/20 0.50
HSD17B10 Q99714 1/20 0.50
HTT P42858 3/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8862565 0.88 MAPT (0.59) MAPTLMNATHRBGAAMEN1
SCHEMBL8680662 0.87 MAPT (0.55) MAPTLMNATHRBGAAMEN1
SCHEMBL12787017 0.86 MAPT (0.50) MAPTLMNATHRBGAAMEN1
SCHEMBL29949228 0.84 MAPT (0.73) MAPTLMNATHRBGAAMEN1
SCHEMBL8685153 0.83 MAPT (0.57) MAPTLMNATHRBGAAMEN1
SCHEMBL16315815 0.82 MAPT (0.56) MAPTLMNATHRBGAAMEN1
SCHEMBL11785840 0.81 MAPT (0.55) MAPTLMNATHRBGAAMEN1
SCHEMBL11787085 0.81 MAPT (0.55) MAPTLMNATHRBGAAMEN1
SCHEMBL12787009 0.80 MEN1 (0.50) MAPTLMNATHRBGAAMEN1
SCHEMBL29783017 0.80 MAPT (0.73) MAPTLMNATHRBGAAMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110059545-A1 TIME-TEMPERATURE INDICATOR BASED ON OLIGOMERIC SPIROAROMATICS FRESHPOINT HOLDINGS SA (CH) 2011-03-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110059545-A1 TIME-TEMPERATURE INDICATOR BASED ON OLIGOMERIC SPIROAROMATICS CCND3, CCNT1, SCO2 MAPT 3910/4885LMNA 716/4885THRB 823/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.